Daily Market Updates: Moderna shares surge after promising cancer-vaccine trial update

Earnings

Home›Earnings›Previews›Moderna shares surge after promising cancer-vaccine tr…

Moderna shares surge after promising cancer-vaccine trial update

Reported · Written up by our desk · Previews

Moderna’s stock jumped sharply after the company shared encouraging results tied to a cancer-vaccine approach.

MarketWatch reports the candidate combines an mRNA therapy with Keytruda, a cancer drug.

The update focused on pairing the mRNA platform with an existing oncology treatment, reflecting an effort to improve cancer outcomes through the combined regimen.

← Newer storyTreasury to double long-end liquidity support buyback size from Sept.…Older story →Amazon boosts northwest Louisiana data center spending to about $18B

More like this

EarningsTesla Cybercab rollout in Austin could pressure ride-hailing margins

EarningsPony AI expands robotaxi fleet as Q2 revenue rises nearly 69%

EarningsRetail earnings week begins with signals on consumer spending

EarningsModerna stock jumps on interim skin cancer trial success

EarningsAmazon boosts northwest Louisiana data center spending to about $18B

Sources

MarketWatchModerna’s stock doubles on promising cancer-vaccine results

Earnings

Moderna shares surge after promising cancer-vaccine trial update

More like this

Sources

Get the close, explained.